BFM
ZVRA icon

Boothbay Fund Management’s Zevra Therapeutics ZVRA Stock Holding History

Boothbay Fund Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-14,943
Closed -$142K – 2496
2025
Q3 		$142K Buy
+14,943
New +$150K ﹤0.01% 1695
2025
Q1 		– Sell
-85,818
Closed -$716K – 1919
2024
Q4 		$716K Buy
+85,818
New +$733K 0.02% 744
2023
Q2 		– Sell
-16,747
Closed -$92.1K – 2462
2023
Q1 		$92.1K Buy
+16,747
New +$88.6K ﹤0.01% 1959
2022
Q1 		– Sell
-12,516
Closed -$109K – 2676
2021
Q4 		$109K Sell
12,516
-399,900
-97% -$3.57M ﹤0.01% 1696
2021
Q3 		$3.85M Sell
412,416
-29,000
-7% -$292K 0.15% 230
2021
Q2 		$5.66M Buy
+441,416
New +$4.74M 0.22% 122

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return